Skip to main content
logo
Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
6.88
-0.11 (-1.57%)
Jul 29, 2026, 4:00 PM EDT - Market closed

Rockwell Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
67.6869.26101.4983.6172.8161.93
Revenue Growth
-30.75%-31.76%21.38%14.84%17.57%-0.43%
Cost of Revenue
56.1357.5684.0174.9168.7364.35
Gross Profit
11.5511.717.488.74.08-2.42
Selling, General & Admin
16.3616.3916.8614.2717.7421.08
Research & Development
--0.021.113.126.84
Total Operating Expenses
16.3616.3916.8815.3720.8627.92
Operating Income
-4.81-4.690.61-6.67-16.78-30.34
Interest Income
0.210.230.090.210.030.02
Interest Expense
-1.13-1.12-1.25-2.3-1.94-2.36
Other Non-Operating Income (Expense)
0.330.270.07-0.32-0-
Total Non-Operating Income (Expense)
-0.59-0.62-1.09-2.41-1.91-2.34
Pretax Income
-5.4-5.31-0.48-9.08-18.69-32.67
Net Income
-5.4-5.31-0.48-9.08-18.69-32.67
Net Income to Common
-5.4-5.31-0.48-8.44-18.68-32.67
Net Income Growth
------
Shares Outstanding (Basic)
443211
Shares Outstanding (Diluted)
443211
Shares Change
13.88%15.83%33.17%63.05%67.77%24.02%
EPS (Basic)
-1.45-1.50-0.30-3.70-13.10-38.30
EPS (Diluted)
-1.45-1.50-0.30-3.70-13.10-38.30
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1.76-1.23.19-9.7-17.21-34.06
Free Cash Flow Growth
-18.66%-----
Free Cash Flow Per Share
0.47-0.331.03-4.16-12.03-39.94
Gross Margin
17.07%16.89%17.23%10.41%5.60%-3.91%
Operating Margin
-7.11%-6.77%0.60%-7.98%-23.05%-48.98%
Profit Margin
-7.98%-7.67%-0.47%-10.86%-25.67%-52.76%
FCF Margin
2.60%-1.73%3.14%-11.60%-23.64%-54.99%
EBITDA
-0.51-0.364.75-3.22-14.19-27.82
EBITDA Margin
-0.76%-0.52%4.68%-3.85%-19.49%-44.92%
EBIT
-4.81-4.690.61-6.67-16.78-30.34
EBIT Margin
-7.11%-6.77%0.60%-7.98%-23.05%-48.98%
SEC Filings: 10-K · 10-Q